Posted in | News | Nanoanalysis | Graphene

OU to Acquire Veeco’s New GENxplor R&D Molecular Beam Epitaxy System

Veeco Instruments Inc. announced today that the University of Oklahoma (OU) will receive the first shipment of Veeco’s new GENxplor™ R&D Molecular Beam Epitaxy (MBE) System early in the fourth quarter. The GENxplor is a fully integrated deposition system that creates high quality epitaxial layers on substrates up to 3” in diameter and is ideal for cutting edge research on a wide variety of materials including GaAs, nitrides, and oxides.

“The University of Oklahoma is proud to be the first university in the world that will have the new GENxplor,” said Dr. Michael Santos, University of Oklahoma Professor in Engineering Physics. “The proven growth chamber and enhanced features of the GENxplor, including robust process flexibility and convenient access to effusion cells, are ideal for the materials research we are conducting for technologies such as lasers, photo detectors, and solar cells. We have two other Veeco MBE systems in our lab that have performed very well.”

In addition to receiving the first tool, Dr. Santos is scheduled to discuss his latest MBE research at the North America MBE Conference (NAMBE), occurring today in Banff, Canada.

“The University of Oklahoma is at the forefront of compound semiconductor materials research, so it is quite fitting that they are receiving the first GENxplor,” commented Jim Northup, Vice President, General Manager of Veeco’s MBE Operations. “It has been designed specifically for the R&D community, combining an easy to use platform with our world-class MBE performance.” Please visit this link for more information about Dr. Santos’ III-V research focus areas: http://mbsantos.weebly.com/.

About GENxplor

Veeco's GENxplor features an efficient single frame design that combines all vacuum hardware with on-board electronics to make it up to 40% smaller than other MBE systems, saving valuable lab space. Because the manual system is integrated on a single frame, installation time is reduced. The open architecture design of the GENxplor also improves ease-of-use, provides convenient access to effusion cells, and allows easier serviceability when compared to other MBE systems. When coupled with Veeco’s recently introduced retractable sources, the GENxplor system represents the state-of-the-art in oxide materials research.

About Veeco

Veeco’s process equipment solutions enable the manufacture of LEDs, flexible OLED displays, power electronics, hard drives, MEMS and wireless chips. We are the market leader in MOCVD, MBE, Ion Beam and other advanced thin film process technologies. Our high performance systems drive innovation in energy efficiency, consumer electronics and network storage and allow our customers to maximize productivity and achieve lower cost of ownership. For information on our company, products and worldwide service and support, please visit www.veeco.com.

Source: http://www.veeco.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Veeco. (2019, February 11). OU to Acquire Veeco’s New GENxplor R&D Molecular Beam Epitaxy System. AZoNano. Retrieved on April 19, 2024 from https://www.azonano.com/news.aspx?newsID=28455.

  • MLA

    Veeco. "OU to Acquire Veeco’s New GENxplor R&D Molecular Beam Epitaxy System". AZoNano. 19 April 2024. <https://www.azonano.com/news.aspx?newsID=28455>.

  • Chicago

    Veeco. "OU to Acquire Veeco’s New GENxplor R&D Molecular Beam Epitaxy System". AZoNano. https://www.azonano.com/news.aspx?newsID=28455. (accessed April 19, 2024).

  • Harvard

    Veeco. 2019. OU to Acquire Veeco’s New GENxplor R&D Molecular Beam Epitaxy System. AZoNano, viewed 19 April 2024, https://www.azonano.com/news.aspx?newsID=28455.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.